Astellas Pharma Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
1/10
|
174.58 | 110.96 | 57.34% | 55.79 | +212.94% |
| P/S |
|
1.86 | 74.98 | -97.53% |
|
|
| P/BV |
|
1.86 | 70.27 | -97.35% |
|
|
| P/FCF |
|
44.57 | 85.21 | -47.7% |
|
|
| Ev/Ebitda |
|
18.66 | 17.08 | 9.29% |
|
|
| Ev/S |
|
2.27 | 72.29 | -96.86% |
|
|
| Ev/FCF |
|
40.52 | 27.51 | 47.29% |
|
|
| E/P |
|
0.0043 | -0.1872 | -102.3% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
4/10
|
12.18 | -77.56 | -115.7% | 15.28 | -20.3% |
| ROE |
|
1.1 | -9.31 | -111.8% |
|
|
| ROA |
|
0.5657 | -9.75 | -105.8% |
|
|
| ROIC |
|
12.61 | 9.09 | 38.68% |
|
|
| ROS |
|
1.06 | -144.19 | -100.74% |
|
|
| ROCE |
|
1.64 | 5.62 | -70.8% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
0/10
|
5.15 | -1.04 | -594.33% | 2.65 | +93.93% |
| Nеt Debt/Ebitda |
|
3.43 | 12.5 | -72.57% |
|
|
| Debt/Ratio |
|
0.2817 | 0.1401 | 101.11% |
|
|
| Debt/Equity |
|
0.6302 | 24.46 | -97.42% |
|
|
| Debt/Net Income |
|
59 | -1.96 | -3113.25% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
10/10
|
6.24 | 2.66 | 134.39% | 3.86 | +61.81% |
| Number of years of dividend growth |
|
2 | 1.28 | 55.79% | ||
| DSI |
|
0.9286 | 0.7385 | 25.73% |
|
|
| Average dividend growth |
|
9.61 | -18.33 | -152.42% |
|
|
| Average percentage for 5 years |
|
3.86 | 1.91 | 102.03% |
|
|
| Average percentage for payments |
|
164.66 | 33.86 | 386.27% |
|
|
| Difference from average difference in sector |
|
3.58 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
4/10
|
23.28 | 106.99 | -78.24% | ||
| Growth impulse Ebitda in 5 years |
|
-37.94 | 90.7 | -141.83% | ||
| Growth impulse Net Income in 5 years |
|
-91.28 | 77.88 | -217.21% | ||
| Growth impulse FCF in 5 years |
|
-37.56 | 9.1 | -512.75% | ||
| Growth impulse EPS in 5 years |
|
-90.9 | 9.8 | -1027.55% |
IP Score
4.35/10
